SightLine Partners

SightLine Partners LLC is a private equity and venture capital firm established in 2004, headquartered in Bloomington, Minnesota, with an additional office in Palo Alto, California. The firm specializes in investing in later-stage healthcare companies across the United States, focusing on medical technology, biotechnology, medical devices, diagnostics, and healthcare services. It targets investments in innovative medical devices and technologies, particularly in therapeutic areas such as vascular diseases, diabetes, and pulmonary conditions. SightLine Partners looks for opportunities in companies that can enhance the diagnosis, treatment, and prevention of major diseases, including those related to the nervous and immune systems, cardiovascular health, and oncology. The firm typically invests between $2 million and $8 million in its portfolio companies, structuring investments as preferred stock, with an exit strategy within five years.